Anticancer

(-)-Lariciresinol
Catalog No: CFN92501

Lariciresinol administration can inhibit the tumor growth and tumor angiogenesis, conceivable importance of dietary lignan lariciresinol in inhibition of breast cancer development.

Zingibroside R1
Catalog No: CFN92517

Zingibroside R1 has anti-HIV-1 activity.

Paederosidic acid
Catalog No: CFN92524

Paederosidic acid has significant anti-tumor, anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain, and it up-regulates expressions of GAD 65, may be a promising future therapeutic agent for treatment of epilepsy.

1-Hydroxy-2-methylanthraquinone
Catalog No: CFN92567

1-Hydroxy-2-methylanthraquinone exhibits promising larvicidal activity.

Berberrubine
Catalog No: CFN90509

Berberrubine possesses diverse pharmacological activities, including glucose-lowering, lipid-lowering, anti-inflammatory, and anti-tumor effects. Berberrubine dose-dependently inhibits IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha.